INVITATION 2018 FULL-YEAR RESULTS GAM HOLDING AG

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
19
INVITATION 2018 FULL-YEAR RESULTS GAM HOLDING AG

Presentation for media, analysts and investors Thursday 21 February 2019 | From 8:30am (CET) | Zurich

 

Dear Sir/Madam,

We cordially invite you to join the presentation of GAM's 2018 full-year results which will be held via webcast exclusively and which will take place as follows:

Programme
Date Thursday, 21 February 2019
Time 8:30am CET (7:30am GMT, 2:30am EST)
Web location www.gam.com

The results will be presented via a webcast by Group CEO David Jacob and Group CFO Richard McNamara.

To join the online presentation, please complete the  registration form  by Friday, 15 February 2019. The webcast link will be made available on  www.gam.com  on the event day.

Please note that there will be no facility to ask questions via the webcast but only via telephone dial-in. You will need to log in and register prior to the event.

Detailed information on the full-year 2018 results of GAM Holding AG will be available on  www.gam.com  from 7:00am CET on Thursday, 21 February 2019.

Kind regards,

Marc Duckeck Media Relations GAM Holding AG Patrick Zuppiger Investor Relations GAM Holding AG Tobias Plangg Media Relations GAM Holding AG Jessica Grassi Investor Relations GAM Holding AG
To listen in to the presentation by telephone:
UK Free Phone 0800 376 7922
UK Local 0844 571 8892
USA Free Phone 18669661396
Switzerland Free Phone 0800 740 377
Switzerland Local (Bern) 031 580 0059
Germany Free Phone 0800 723 4866
Germany Local (Frankfurt) 0692 443 7351
Participant Std International Dial-In +44 (0) 2071 928000

Please provide the code  5782657  when requested. Please dial-in approximately 10 minutes before the start of the presentation in order to register. Telephone participants will have the opportunity to ask questions after the presentation.

Presentation playback:
UK National Call 0871 700 0471
UK FreeCall 0808 238 0667
Germany 0302 150 2868
Std International +44 (0) 3333009785

Please enter the code  5782657  when requested. This playback facility will be available after the presentation from 21 February 2019 at 14:30 until 24 February 2019 at 14:30 CET.

To watch the webcast of the presentation: The webcast will be accessible, both live and as a replay, on  www.gam.com , along with the accompanying presentation slides. Please note that there will be no facility to ask questions via the webcast but only via telephone dial-in. You will need to log in and register prior to the event.

 

Important legal information This email is for information only and is not an invitation to invest in any GAM product. Nothing contained herein constitutes investment, legal, tax or other advice nor is it to be solely relied on in making an investment or other decision. It is not an invitation to invest in GAM products and is by way of information only. In the United Kingdom, this material has been issued and approved by GAM London Ltd, 20 King Street, London, SW1Y 6QY, authorised and regulated by the Financial Conduct Authority.

Using your personal information GAM Holding AG and its subsidiaries ( GAM, we/us/our ) will collect and use information about you in the course of your interactions with us. Full details about the data types we collect and what we use this for and your related rights is set out in our online  privacy policy . Please familiarise yourself with this policy and check it from time to time for updates as it supplements this notice.

Click here to unsubscribe from this email  You will no longer receive this particular communication but will continue to receive any other items you are currently subscribed to.

Click here to unsubscribe from all mailings  You will not receive any further communication by email, including; marketing messages, commentaries and reporting publications.

We collect email tracking information about message opens and clicks on included hyperlinks. We use this information to improve the quality and relevance of our email communications. Please visit our  privacy policy  to read more on this subject or to opt out of email tracking.

View online version

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 124

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 90

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Grand Circle Cruise Line Achieves Top Honors for 2025 Travel

Updated Category News Views 271

Grand Circle Cruise Line Recognized Among the Best Grand Circle Cruise Line (GCCL) recently earned the impressive title of #2 Best River Cruise Line in the Travel + Leisure's 2025 World's Best Awards. This accolade showcases the hard work and dedication of the teams and crew members who make each journey remarkable along Europe’s scenic rivers. Celebrating a Special...

Continue Reading
Lancaster Resources Achieves License Approval for Gold Project Exploration

Updated Category News Views 145

Lancaster Resources Secures Approval for Exploration License Vancouver-based Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) is pleased to announce a significant milestone in its gold exploration journey. The company has received confirmation of an Exploration License for the Lake Cargelligo Gold Project from the State of New South Wales. Covering an impressive...

Continue Reading
Future of Vitrectomy Devices: Growth Insights and Trends

Updated Category News Views 93

Understanding the Vitrectomy Devices Market Growth The vitrectomy devices industry has become increasingly vital in treating various eye-related disorders, with significant growth projected in the coming years. By focusing on technological advancements and heightened awareness of eye health, the market is set to expand impressively. According to a recent report, the...

Continue Reading
Exploring RDG Mining's Innovative Cloud Mining Solution

Updated Category News Views 158

Understanding RDG Mining's Latest Offerings In recent times, the popularity of cryptocurrency has surged significantly, with platforms like RDG Mining capitalizing on this trend. RDG Mining is a leading cloud mining service based in the UK that has captured the interest of over 7.5 million users globally, particularly with the rise in various cryptocurrencies, including...

Continue Reading
Pharma Equity Group Updates Its Financial Reporting Strategy

Updated Category News Views 82

Revisions to Financial Reporting and Calendar The board of Pharma Equity Group A/S has recently made the strategic decision to submit only half-yearly financial reports moving forward. This adjustment reflects a shift in focus towards more impactful reporting. As a result, the financial calendar for 2025 has been updated to better align with these new reporting practices....

Continue Reading